AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the quarter and year ended 31st March 202301-06-2023
01-06-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Pursuant to the Regulation 23(9) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the disclosure of Related Party Transactions on a Standalone basis, for the half year ended on March 31, 2023.30-05-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Outcome Of The Board Meeting
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 30, 2023) had inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2023, as recommended by the Audit Committee at its meeting held today (May 30, 2023) The same along with the Independent Auditor's Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2022-23. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM.30-05-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Outcome for Outcome Of The Board Meeting
In terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI LODR), we wish to inform that the Board of Directors of the Company at its meeting held today (May 30, 2023) had inter-alia: (i) Approved the Audited Financial Results for the quarter and year ended March 31, 2023, as recommended by the Audit Committee at its meeting held today (May 30, 2023) The same along with the Independent Auditor's Report issued by M/s. B S R & Co. LLP, Statutory Auditors of the Company is enclosed. (ii) Recommended Final Dividend of Rs. 2.60 per equity share on 2,92,30,630 shares of Re. 1 each fully paid up for the financial year 2022-23. The Final dividend if approved at the Annual General Meeting will be paid to eligible shareholders within 30 days of AGM.30-05-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Submission of Annual Secretarial Compliance Report for the year ended March 31, 202329-05-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Update on board meeting
The Board Meeting to be held on 27/05/2023 has been revised to 30/05/2023 Please refer to our earlier intimation about Board Meeting scheduled on 27th May 2023. we wish to inform that the said meeting of the Board of Directors is re-scheduled and will now be held on Tuesday, the 30th May, 2023 thru Video Conferencing23-05-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Board Meeting Intimation for Intimation Under Regulation 29(1) Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 (SEBI LODR) That A Meeting Of The Board Of Directors Is Scheduled To Be Held On Saturday, The 27Th May, 2023 Thru Video Conferencing
AMRUTANJAN HEALTH CARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 ,inter alia, to consider and approve (i) Audited Financial Results along with the Audit Report by the Statutory Auditors for the quarter and year ended March 31 2023. (ii) Declaration of Final Dividend for the financial year 2022-23; if any19-05-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Certificate Under Regulation 40(9) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements)Regulations 2015.
Pursuant to above Regulation please find the enclosed the Certificate issued by the Practising Company secretaries, M/s. SPNP and Associates for the year ended March 31 202328-04-2023
AMRUTANJAN HEALTH CARE LTD.-$ - 590006 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyAMRUTANJAN HEALTH CARE LTD.- 2CIN NO.L24231TN1936PLC000017 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: M SRINIVASAN Designation: Company Secretary and Compliance officer EmailId: [email protected] Name of the Chief Financial Officer: N SWAMINATHAN Designation: CFO EmailId: [email protected] Date: 28/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.28-04-2023